Aggressive pituitary tumours and carcinomas: two sides of the same coin?

DOI Web Site XML 被引用文献2件
  • Jacqueline Trouillas
    1Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France
  • Pia Burman
    2Endocrinology, Skåne University Hospital, Malmo, Sweden
  • Ann McCormack
    4Department of Endocrinology, St Vincent’s Hospital, Sydney, New South Wales, Australia
  • Stephan Petersenn
    6Center for Endocrine Tumors, ENDOC, Hamburg, Germany
  • Vera Popovic
    7School of Medicine, University of Belgrade, Belgrade, Serbia
  • Olaf Dekkers
    8Departments of Clinical Epidemiology and Endocrinology, Leids Universitair Medisch Centrum Ringgold Standard Institution, Leiden, Zuid-Holland, Netherlands
  • Gerald Raverot
    1Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France

説明

<jats:p>The European Society of Endocrinology (ESE) survey reported on the largest cohort of 125 aggressive pituitary tumours (APT) and 40 pituitary carcinomas (PC). Whilst the survey focused on treatment effectiveness, all pathological data were not explored in detail. Here, we comment on some interesting pathological findings, notably the difference between APT and PC.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ